| Ytd | 289.88% | |
| 1y | 347.59% |
| Open | 123.49 | Prev Close | 124.88 | Low | 123.08 | High | 124.97 | Mkt Cap | 7.70B |
| Vol | 434.85K | Avg Vol | 1.79M | EPS | -2.22 | P/E | -55.70 | Forward P/E | -182.64 |
| Beta | 2.14 | Short Ratio | 6.88 | Inst. Own | 119.39% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 89.39 | 200-d Avg | 54.97 | 1yr Est | 105.30 |
On August 07, 2026, Twist Bioscience Corp (TWST) shares rose by 6.0%, bringing the current price to
Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report)'s share price shot up 10.3% during mid
Twist Bioscience's stock has surged in 2026 on the back of improved growth and growing optimism abou
Twist Bioscience Corporation (Nasdaq: TWST) (âTwistâ), a mid-cap growth and value biotech compan
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST) (“Twist”),
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST) (“Twist”),
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, T
First Trust Advisors LP acquired a new position in Twist Bioscience Corporation (NASDAQ: TWST) in th
Twist Bioscience Corporation (TWST) Q3 2026 Earnings Call Transcript
Twist Bioscience Corporation (NASDAQ:TWST) stock is up on Monday as the company reported its fiscal
Twist Bioscience NASDAQ: TWST reported fiscal 2026 third-quarter revenue of $118.4 million, up 23% f
Twist Bioscience (TWST) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus
[url="]Twist Bioscience Corporation[/url] (NASDAQ: TWST), a mid-cap growth and value biotech company
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap
Allspring Global Investments Holdings LLC purchased a new position in shares of Twist Bioscience Cor
Thrivent Small Cap Growth Fund returned 25.54% during the quarter, modestly underperforming the Russ
Artisan Mid Cap Fund portfolio generated strong absolute returns and outpaced the Russell Midcap® Gr
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap
Canaccord Genuity analyst Kyle Mikson maintains Twist Bioscience (NASDAQ:TWST) with a Buy and rai
The researchers said the findings are not causal and urged more research into whether GLP-1s reduce
12,000 shares were exercised from options and sold for a total of ~$673,000 on May 12, 2026. All sha
Top Wall Street analysts changed outlook on top names. Check analyst ratings page for full changes.
Companies Reporting Before The Bell • W.W. Grainger (NYSE:GWW) is likely to report quarterly earnin
Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first
Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly e
Friday's session saw 104 companies set new 52-week lows.
On Thursday, 185 companies achieved new lows for the year.
On Wednesday, 345 companies set new 52-week lows.
On Wednesday, 220 stocks hit new 52-week lows.
On Monday, 76 companies set new 52-week lows.
On Wednesday, 81 companies hit new 52-week lows.
U.S. stocks traded mixed, with the Dow Jones gaining around 100 points on Tuesday. Here are some big
On Friday, 497 companies set new 52-week lows.
Gainers
On Tuesday, 951 companies hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report
Wednesday's session saw 784 companies set new 52-week lows.
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week
Tuesday's session saw 729 companies set new 52-week lows.